RECRUITING

Heart Failure Precision Medicine Study

Description

The study aims to test the hypothesis that multi-omics studies can identify Heart Failure profiles at risk of adverse outcomes and evaluate a telemonitoring intervention in the optimization of guideline-directed medical therapy.

Conditions

Study Overview

Study Details

Study overview

The study aims to test the hypothesis that multi-omics studies can identify Heart Failure profiles at risk of adverse outcomes and evaluate a telemonitoring intervention in the optimization of guideline-directed medical therapy.

Heart Failure Precision Medicine Study

Heart Failure Precision Medicine Study

Condition
Heart Failure
Intervention / Treatment

-

Contacts and Locations

Sacramento

UC Davis Medical Center, Sacramento, California, United States, 95817

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Diagnosis of Heart failure
  • * Objective evidence of cardiac abnormality of structure or function (abnormal ECHO) or elevated levels of B-type natriuretic peptide (\>100 pg/ml)
  • * HF stage B-D and class I-IV
  • * Patients unable to consent
  • * Inability to comply with the protocol and follow-up requirements
  • * Patients unable to use a smartphone
  • * Patients assessed irregularly (less than two visits in one year)
  • * History of HTx
  • * Use of Mechanical circulatory support device (MCSD)
  • * Comorbidities that, according to the PI, have the potential to interfere with the interpretation of the results

Ages Eligible for Study

21 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of California, Davis,

Martin Cadeiras, MD, PRINCIPAL_INVESTIGATOR, University of California, Davis

Study Record Dates

2026-10-16